share_log

Ladenburg Thalmann Downgrades Ayala Pharmaceuticals to Neutral

Benzinga ·  Nov 17, 2023 03:12

Ladenburg Thalmann analyst Ahu Demir downgrades Ayala Pharmaceuticals (OTC:ADXS) from Buy to Neutral.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment